A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia

Clinical trial NCT03519711 · COMPLETED

Trial details

NCT number: NCT03519711
Sponsor: PTC Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

BH4 Deficiency Hyperphenylalaninemia

Start date: 2019-01-03
Primary completion: 2020-10-02
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.